VACCINUM
VACCINUM is a Swiss-based life sciences and vaccines consulting practice offering a range of services covering major activities in the fields of Biological and Biomedical Technologies, such as Vaccine Development, Cancer Therapy, Gene Therapy and Editing. We also advise, support and facilitate: technology transfers, partnerships and project development.
VACCINUM collaborates with exceptionally qualified Consultants and Trainers of various specialization in Life and Medical Sciences; Academic, Industrial and Biotech fields. We do not only know the industry inside and out, but also truly understand the gaps between academic and industrial Institutions. We bridge the essentials and understand your business and what it takes to be successful.
![](https://static.wixstatic.com/media/3bf8a58c84dc48d6a4cc9c5a340703fa.jpg/v1/fill/w_385,h_258,al_c,q_80,usm_0.66_1.00_0.01,enc_auto/3bf8a58c84dc48d6a4cc9c5a340703fa.jpg)
ABOUT
Our Team
![](https://static.wixstatic.com/media/b5f078_edf74249ecb44c47a626016ace120107~mv2.jpg/v1/fill/w_95,h_94,al_c,q_80,usm_0.66_1.00_0.01,enc_auto/b5f078_edf74249ecb44c47a626016ace120107~mv2.jpg)
Hussein Naim, General Manager
Phone: + 41 31 381 5066
Professor Dr. Hussein Y. Naim is the General Manager of VACCINUM. He holds a Ph.D. in Biochemistry from the University of Bern-Switzerland and accomplished his expertise at the University of Texas at Dallas. He held Faculty positions at UT Southwestern Medical Center at Dallas and the Institute of Molecular Biology of the University of Zurich. His laboratory developed the first genetically engineered live attenuated recombinant virus vector and transferred this technology (including training) in Europe and the USA.
Dr. Naim also held the Director of Vaccine Research position at Berna Biotech and Crucell, Switzerland. Dr. Naim was invited to join several International Universities as a Guest Professor. He is a well-known expert in various fields of translational research and lectured at prominent Universities and Scientific Conferences on Novel Biotechnologies, Vaccines and Gene Therapy using viruses.
Dr. Naim was awarded several competitive grants from the EU and the NIH. He served and is serving on the reviewing boards of several National and International Health Authorities such as the WHO, EU and Swiss Medical Authority.